These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32347895)

  • 1. Internet Searches for Unproven COVID-19 Therapies in the United States.
    Liu M; Caputi TL; Dredze M; Kesselheim AS; Ayers JW
    JAMA Intern Med; 2020 Aug; 180(8):1116-1118. PubMed ID: 32347895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.
    Principi N; Esposito S
    Lancet Infect Dis; 2020 Oct; 20(10):1118. PubMed ID: 32311322
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxychloroquine prophylaxis for COVID-19 contacts in India.
    Rathi S; Ish P; Kalantri A; Kalantri S
    Lancet Infect Dis; 2020 Oct; 20(10):1118-1119. PubMed ID: 32311324
    [No Abstract]   [Full Text] [Related]  

  • 4. Chloroquine as a prophylactic agent against COVID-19?
    Gendrot M; Javelle E; Clerc A; Savini H; Pradines B
    Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
    Patrì A; Fabbrocini G
    J Am Acad Dermatol; 2020 Jun; 82(6):e221. PubMed ID: 32283237
    [No Abstract]   [Full Text] [Related]  

  • 6. Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
    Thomson K; Nachlis H
    JAMA; 2020 Oct; 324(13):1282-1283. PubMed ID: 32870235
    [No Abstract]   [Full Text] [Related]  

  • 7. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
    Sahraei Z; Shabani M; Shokouhi S; Saffaei A
    Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
    [No Abstract]   [Full Text] [Related]  

  • 8. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
    D'Acquarica I; Agranat I
    Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
    White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J
    PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?
    Allam MF; Andraous F
    Cent Eur J Public Health; 2020 Sep; 28(3):246-247. PubMed ID: 32997483
    [No Abstract]   [Full Text] [Related]  

  • 11. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
    Shah S; Das S; Jain A; Misra DP; Negi VS
    Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.
    Jakhar D; Kaur I
    Nat Med; 2020 May; 26(5):632. PubMed ID: 32269358
    [No Abstract]   [Full Text] [Related]  

  • 13. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
    Lebin JA; LeSaint KT
    West J Emerg Med; 2020 Jun; 21(4):760-763. PubMed ID: 32726238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
    Islam M
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention.
    Tarek M; Savarino A
    Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):715-723. PubMed ID: 32780273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
    Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
    Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
    Yazdany J; Kim AHJ
    Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings.
    Mvumbi DM
    Med Hypotheses; 2020 Oct; 143():109912. PubMed ID: 32498009
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug Evaluation during the Covid-19 Pandemic.
    Rome BN; Avorn J
    N Engl J Med; 2020 Jun; 382(24):2282-2284. PubMed ID: 32289216
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of Trump's Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study.
    Niburski K; Niburski O
    J Med Internet Res; 2020 Nov; 22(11):e20044. PubMed ID: 33151895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.